Serum miR-210-3p as a Potential Noninvasive Biomarker of Lung Adenocarcinoma: A Preliminary Study

scientific article published on 05 April 2019

Serum miR-210-3p as a Potential Noninvasive Biomarker of Lung Adenocarcinoma: A Preliminary Study is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1089/GTMB.2018.0275
P698PubMed publication ID30950648

P50authorMichał Seweryn KarbownikQ91861295
Janusz SzemrajQ91968919
P2093author name stringJózef Kozak
Michał Suwalski
Weronika Zofia Świtlik
P433issue5
P921main subjectbiomarkerQ864574
P304page(s)353-358
P577publication date2019-04-05
P1433published inGenetic Testing and Molecular BiomarkersQ15753742
P1476titleSerum miR-210-3p as a Potential Noninvasive Biomarker of Lung Adenocarcinoma: A Preliminary Study
P478volume23

Reverse relations

cites work (P2860)
Q89697494MiRNAs and LncRNAs: Dual Roles in TGF-β Signaling-Regulated Metastasis in Lung Cancer
Q99565934Serum miR-339-3p as a potential diagnostic marker for non-small cell lung cancer
Q103760252miRNAs in lung cancer. A systematic review identifies predictive and prognostic miRNA candidates for precision medicine in lung cancer

Search more.